Outcomes in tricuspid valve intervention

Session comprising selected EuroPCR 2026 late-breaking trials submissions

Anchorperson: F. Praz

Spokesperson: R. Hahn

Summary

This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.

Presentations available when logged in:

The Cardiovalve replacement system for tricuspid regurgitation, TARGET study interim results
Clinical impact of atrial fibrillation on tricuspid TEER
The less the better: mild vs. moderate residual tricuspid regurgitation after tricuspid TEER: insights from EuroTR
Afterload mismatch after transcatheter tricuspid intervention in the TriValve registry
Long-term outcomes of bioprosthetic valves in the tricuspid position: meta-analysis of over 20 year

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Outcomes in tricuspid valve intervention

Session comprising selected EuroPCR 2026 late-breaking trials submissions

Log in or create account for free